12/3
04:33 pm
scnx
Scienture (NASDAQ:SCNX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings .
Low
Report
Scienture (NASDAQ:SCNX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings .
12/2
08:17 am
scnx
SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025 [Yahoo! Finance]
Low
Report
SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025 [Yahoo! Finance]
12/2
08:05 am
scnx
SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025
Low
Report
SCIENTURE to Participate in the iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9–10, 2025
11/27
02:53 pm
scnx
Scienture (NASDAQ:SCNX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings .
Low
Report
Scienture (NASDAQ:SCNX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings .
11/13
08:38 am
scnx
SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/13
08:05 am
scnx
SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update
Medium
Report
SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update
11/4
08:05 am
scnx
SCIENTURE Announces Addition of Arbli™ (Losartan Potassium) to Formularies of Major National Health Plans
Low
Report
SCIENTURE Announces Addition of Arbli™ (Losartan Potassium) to Formularies of Major National Health Plans
10/23
08:05 am
scnx
SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli™ (Losartan Potassium)
High
Report
SCIENTURE Announces Start of Commercial Sales and Fulfillment of First Orders for Arbli™ (Losartan Potassium)
11/18
06:01 am
scnx
Form 8-K Scienture Holdings, Inc. For: Nov 17
High
Report
Form 8-K Scienture Holdings, Inc. For: Nov 17
11/14
05:01 pm
scnx
Form 8-K Scienture Holdings, Inc. For: Nov 12
Medium
Report
Form 8-K Scienture Holdings, Inc. For: Nov 12
11/14
04:35 pm
scnx
Form SCHEDULE 13G/A Scienture Holdings, Inc. Filed by: L1 Capital Global Opportunities Master Fund, Ltd.
Medium
Report
Form SCHEDULE 13G/A Scienture Holdings, Inc. Filed by: L1 Capital Global Opportunities Master Fund, Ltd.
11/12
05:31 pm
scnx
Form 10-Q Scienture Holdings, Inc. For: Sep 30
Medium
Report
Form 10-Q Scienture Holdings, Inc. For: Sep 30
11/7
05:00 pm
scnx
Form 424B5 Scienture Holdings, Inc.
Medium
Report
Form 424B5 Scienture Holdings, Inc.
10/30
05:16 pm
scnx
Form 8-K Scienture Holdings, Inc. For: Oct 24
Low
Report
Form 8-K Scienture Holdings, Inc. For: Oct 24
10/24
05:14 pm
scnx
Form 424B5 Scienture Holdings, Inc.
High
Report
Form 424B5 Scienture Holdings, Inc.
10/24
05:06 pm
scnx
Form 8-K Scienture Holdings, Inc. For: Oct 20
High
Report
Form 8-K Scienture Holdings, Inc. For: Oct 20
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register